Paper Tools Add to my Library Share How would you like to share? Facebook Twitter LinkedIn Back to the Top
Kalia LV. First phase 3 trial of GLP-1 receptor agonist for neurodegeneration. Lancet. 2025 Feb 4; Epub 2025 Feb 4 PubMed. Recommends Please login to recommend the paper. Comments No Available Comments Make a Comment To make a comment you must login or register.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.